Review
Open access
Sep 2026
Digital therapeutics and mHealth applications in cardiovascular prevention: strongest evidence in hypertension and emerging perspectives in dyslipidemia
Future studies should distinguish between digital therapeutics, mHealth tools, telemonitoring systems, and digital ecosystems, and should evaluate clinically meaningful endpoints, safety, cost-effectiveness, and long-term sustainability.
Arkadiusz Wysocki, Małgorzata Wierzowiecka, A. Niklas
· Frontiers in Digital Health · 0 citations